Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Lung transplantation, ex-vivo reconditioning and regeneration: state of the art and perspectives.

Rosso L, Zanella A, Righi I, Barilani M, Lazzari L, Scotti E, Gori F, Mendogni P.

J Thorac Dis. 2018 Jul;10(Suppl 20):S2423-S2430. doi: 10.21037/jtd.2018.04.151. Review.

2.

Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation.

Trento C, Bernardo ME, Nagler A, Kuçi S, Bornhäuser M, Köhl U, Strunk D, Galleu A, Sanchez-Guijo F, Gaipa G, Introna M, Bukauskas A, Le Blanc K, Apperley J, Roelofs H, Van Campenhout A, Beguin Y, Kuball J, Lazzari L, Avanzini MA, Fibbe W, Chabannon C, Bonini C, Dazzi F.

Biol Blood Marrow Transplant. 2018 Jul 20. pii: S1083-8791(18)30402-6. doi: 10.1016/j.bbmt.2018.07.015. [Epub ahead of print]

3.

Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer.

Siravegna G, Lazzari L, Crisafulli G, Sartore-Bianchi A, Mussolin B, Cassingena A, Martino C, Lanman RB, Nagy RJ, Fairclough S, Rospo G, Corti G, Bartolini A, Arcella P, Montone M, Lodi F, Lorenzato A, Vanzati A, Valtorta E, Cappello G, Bertotti A, Lonardi S, Zagonel V, Leone F, Russo M, Balsamo A, Truini M, Di Nicolantonio F, Amatu A, Bonazzina E, Ghezzi S, Regge D, Vanzulli A, Trusolino L, Siena S, Marsoni S, Bardelli A.

Cancer Cell. 2018 Jul 9;34(1):148-162.e7. doi: 10.1016/j.ccell.2018.06.004.

PMID:
29990497
4.

Low-affinity Nerve Growth Factor Receptor (CD271) Heterogeneous Expression in Adult and Fetal Mesenchymal Stromal Cells.

Barilani M, Banfi F, Sironi S, Ragni E, Guillaumin S, Polveraccio F, Rosso L, Moro M, Astori G, Pozzobon M, Lazzari L.

Sci Rep. 2018 Jun 18;8(1):9321. doi: 10.1038/s41598-018-27587-8.

5.

FGF23 and Fetuin-A Interaction in the Liver and in the Circulation.

Mattinzoli D, Ikehata M, Tsugawa K, Alfieri CM, Dongiovanni P, Trombetta E, Valenti L, Puliti A, Lazzari L, Messa P.

Int J Biol Sci. 2018 Apr 25;14(6):586-598. doi: 10.7150/ijbs.23256. eCollection 2018.

6.

Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapies.

Russo M, Lamba S, Lorenzato A, Sogari A, Corti G, Rospo G, Mussolin B, Montone M, Lazzari L, Arena S, Oddo D, Linnebacher M, Sartore-Bianchi A, Pietrantonio F, Siena S, Di Nicolantonio F, Bardelli A.

Nat Commun. 2018 Jun 12;9(1):2287. doi: 10.1038/s41467-018-04506-z.

7.

Cytomegalovirus myocarditis in a patient with systemic lupus erythematosus (SLE) successfully treated with ganciclovir.

Saraca LM, Lazzari L, di Giuli C, Lavagna A, Mezzetti P, Bovelli D, Boschetti E, Francisci D.

IDCases. 2018 Feb 26;12:4-6. doi: 10.1016/j.idcr.2018.02.008. eCollection 2018.

8.

Mesenchymal stem cells encapsulated into biomimetic hydrogel scaffold gradually release CCL2 chemokine in situ preserving cytoarchitecture and promoting functional recovery in spinal cord injury.

Papa S, Vismara I, Mariani A, Barilani M, Rimondo S, De Paola M, Panini N, Erba E, Mauri E, Rossi F, Forloni G, Lazzari L, Veglianese P.

J Control Release. 2018 May 28;278:49-56. doi: 10.1016/j.jconrel.2018.03.034. Epub 2018 Apr 3.

PMID:
29621597
9.

Microtubule defects in mesenchymal stromal cells distinguish patients with Progressive Supranuclear Palsy.

Calogero AM, Viganò M, Budelli S, Galimberti D, Fenoglio C, Cartelli D, Lazzari L, Lehenkari P, Canesi M, Giordano R, Cappelletti G, Pezzoli G.

J Cell Mol Med. 2018 May;22(5):2670-2679. doi: 10.1111/jcmm.13545. Epub 2018 Mar 4.

10.

ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer.

Pietrantonio F, Di Nicolantonio F, Schrock AB, Lee J, Tejpar S, Sartore-Bianchi A, Hechtman JF, Christiansen J, Novara L, Tebbutt N, Fucà G, Antoniotti C, Kim ST, Murphy D, Berenato R, Morano F, Sun J, Min B, Stephens PJ, Chen M, Lazzari L, Miller VA, Shoemaker R, Amatu A, Milione M, Ross JS, Siena S, Bardelli A, Ali SM, Falcone A, de Braud F, Cremolini C.

J Natl Cancer Inst. 2017 Dec 1;109(12). doi: 10.1093/jnci/djx089.

PMID:
29370427
11.

Challenges of running a GMP facility for regenerative medicine in a public hospital.

Viganò M, Giordano R, Lazzari L.

Regen Med. 2017 Oct;12(7):803-813. doi: 10.2217/rme-2017-0051. Epub 2017 Nov 8.

12.

Mitochondrial dysfunction in Parkinsonian mesenchymal stem cells impairs differentiation.

Angelova PR, Barilani M, Lovejoy C, Dossena M, Viganò M, Seresini A, Piga D, Gandhi S, Pezzoli G, Abramov AY, Lazzari L.

Redox Biol. 2018 Apr;14:474-484. doi: 10.1016/j.redox.2017.10.016. Epub 2017 Oct 20.

13.

Intravenous infusion of human bone marrow mesenchymal stromal cells promotes functional recovery and neuroplasticity after ischemic stroke in mice.

Sammali E, Alia C, Vegliante G, Colombo V, Giordano N, Pischiutta F, Boncoraglio GB, Barilani M, Lazzari L, Caleo M, De Simoni MG, Gaipa G, Citerio G, Zanier ER.

Sci Rep. 2017 Jul 31;7(1):6962. doi: 10.1038/s41598-017-07274-w.

14.

Extracellular Vesicle-Shuttled mRNA in Mesenchymal Stem Cell Communication.

Ragni E, Banfi F, Barilani M, Cherubini A, Parazzi V, Larghi P, Dolo V, Bollati V, Lazzari L.

Stem Cells. 2017 Apr;35(4):1093-1105. doi: 10.1002/stem.2557. Epub 2017 Feb 5.

15.

Clinically relevant hydrogel-based on hyaluronic acid and platelet rich plasma as a carrier for mesenchymal stem cells: Rheological and biological characterization.

Vadalà G, Russo F, Musumeci M, D'Este M, Cattani C, Catanzaro G, Tirindelli MC, Lazzari L, Alini M, Giordano R, Denaro V.

J Orthop Res. 2017 Oct;35(10):2109-2116. doi: 10.1002/jor.23509. Epub 2017 Apr 7.

PMID:
28019703
16.

Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer.

Van Emburgh BO, Arena S, Siravegna G, Lazzari L, Crisafulli G, Corti G, Mussolin B, Baldi F, Buscarino M, Bartolini A, Valtorta E, Vidal J, Bellosillo B, Germano G, Pietrantonio F, Ponzetti A, Albanell J, Siena S, Sartore-Bianchi A, Di Nicolantonio F, Montagut C, Bardelli A.

Nat Commun. 2016 Dec 8;7:13665. doi: 10.1038/ncomms13665.

17.

Description of asymptomatic takotsubo cardiomyopathy after dual chamber pacemaker implantation: are inverted T-waves always related to cardiac memory?

Lazzari L, DI Meo F, Crocetti A, Castelli M, Marini C, Donzelli S, Bovelli D, Carreras G, Boschetti E.

Minerva Cardioangiol. 2017 Feb;65(1):108-109. doi: 10.23736/S0026-4725.16.04077-9. No abstract available.

PMID:
27910302
18.

Posttransplantation cyclophosphamide and sirolimus for prevention of GVHD after HLA-matched PBSC transplantation.

Greco R, Lorentino F, Morelli M, Giglio F, Mannina D, Assanelli A, Mastaglio S, Dalto S, Perini T, Lazzari L, Piemontese S, Corti C, Marcatti M, Bernardi M, Lupo Stanghellini MT, Ciceri F, Peccatori J.

Blood. 2016 Sep 15;128(11):1528-31. doi: 10.1182/blood-2016-06-723205. Epub 2016 Aug 5. No abstract available.

19.

Finding a new therapeutic approach for no-option Parkinsonisms: mesenchymal stromal cells for progressive supranuclear palsy.

Canesi M, Giordano R, Lazzari L, Isalberti M, Isaias IU, Benti R, Rampini P, Marotta G, Colombo A, Cereda E, Dipaola M, Montemurro T, Viganò M, Budelli S, Montelatici E, Lavazza C, Cortelezzi A, Pezzoli G.

J Transl Med. 2016 May 10;14(1):127. doi: 10.1186/s12967-016-0880-2.

20.

Hydroquinone induces DNA hypomethylation-independent overexpression of retroelements in human leukemia and hematopoietic stem cells.

Conti A, Rota F, Ragni E, Favero C, Motta V, Lazzari L, Bollati V, Fustinoni S, Dieci G.

Biochem Biophys Res Commun. 2016 Jun 10;474(4):691-695. doi: 10.1016/j.bbrc.2016.05.010. Epub 2016 May 3.

PMID:
27154225
21.

Angiogenic and anti-inflammatory properties of mesenchymal stem cells from cord blood: soluble factors and extracellular vesicles for cell regeneration.

Montemurro T, Viganò M, Ragni E, Barilani M, Parazzi V, Boldrin V, Lavazza C, Montelatici E, Banfi F, Lauri E, Giovanelli S, Baccarin M, Guerneri S, Giordano R, Lazzari L.

Eur J Cell Biol. 2016 Jun-Jul;95(6-7):228-38. doi: 10.1016/j.ejcb.2016.04.003. Epub 2016 Apr 16.

PMID:
27139721
22.

Three-dimensional podocyte-endothelial cell co-cultures: Assembly, validation, and application to drug testing and intercellular signaling studies.

Li M, Corbelli A, Watanabe S, Armelloni S, Ikehata M, Parazzi V, Pignatari C, Giardino L, Mattinzoli D, Lazzari L, Puliti A, Cellesi F, Zennaro C, Messa P, Rastaldi MP.

Eur J Pharm Sci. 2016 Apr 30;86:1-12. doi: 10.1016/j.ejps.2016.02.013. Epub 2016 Feb 23.

PMID:
26924225
23.

A Chemically Defined Medium-Based Strategy to Efficiently Generate Clinically Relevant Cord Blood Mesenchymal Stromal Colonies.

Barilani M, Lavazza C, Boldrin V, Ragni E, Parazzi V, Crosti M, Montelatici E, Giordano R, Lazzari L.

Cell Transplant. 2016;25(8):1501-14. doi: 10.3727/096368916X690827. Epub 2016 Feb 2.

PMID:
26850072
24.

MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutations.

Arena S, Siravegna G, Mussolin B, Kearns JD, Wolf BB, Misale S, Lazzari L, Bertotti A, Trusolino L, Adjei AA, Montagut C, Di Nicolantonio F, Nering R, Bardelli A.

Sci Transl Med. 2016 Feb 3;8(324):324ra14. doi: 10.1126/scitranslmed.aad5640.

25.

Bridge therapy or standard treatment for urgent surgery after coronary stent implantation: Analysis of 314 patients.

De Servi S, Morici N, Boschetti E, Rossini R, Martina P, Musumeci G, D'Urbano M, Lazzari L, La Vecchia C, Senni M, Klugmann S, Savonitto S.

Vascul Pharmacol. 2016 May;80:85-90. doi: 10.1016/j.vph.2015.11.085. Epub 2015 Nov 30.

PMID:
26657879
26.

Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer.

Russo M, Siravegna G, Blaszkowsky LS, Corti G, Crisafulli G, Ahronian LG, Mussolin B, Kwak EL, Buscarino M, Lazzari L, Valtorta E, Truini M, Jessop NA, Robinson HE, Hong TS, Mino-Kenudson M, Di Nicolantonio F, Thabet A, Sartore-Bianchi A, Siena S, Iafrate AJ, Bardelli A, Corcoran RB.

Cancer Discov. 2016 Feb;6(2):147-153. doi: 10.1158/2159-8290.CD-15-1283. Epub 2015 Dec 7.

27.

Obestatin promotes proliferation and survival of adult hippocampal progenitors and reduces amyloid-β-induced toxicity.

Gargantini E, Lazzari L, Settanni F, Taliano M, Trovato L, Gesmundo I, Ghigo E, Granata R.

Mol Cell Endocrinol. 2016 Feb 15;422:18-30. doi: 10.1016/j.mce.2015.11.008. Epub 2015 Nov 14.

PMID:
26586206
28.

Acquired Resistance to the TRK Inhibitor Entrectinib in Colorectal Cancer.

Russo M, Misale S, Wei G, Siravegna G, Crisafulli G, Lazzari L, Corti G, Rospo G, Novara L, Mussolin B, Bartolini A, Cam N, Patel R, Yan S, Shoemaker R, Wild R, Di Nicolantonio F, Bianchi AS, Li G, Siena S, Bardelli A.

Cancer Discov. 2016 Jan;6(1):36-44. doi: 10.1158/2159-8290.CD-15-0940. Epub 2015 Nov 6.

29.

A new three dimensional biomimetic hydrogel to deliver factors secreted by human mesenchymal stem cells in spinal cord injury.

Caron I, Rossi F, Papa S, Aloe R, Sculco M, Mauri E, Sacchetti A, Erba E, Panini N, Parazzi V, Barilani M, Forloni G, Perale G, Lazzari L, Veglianese P.

Biomaterials. 2016 Jan;75:135-147. doi: 10.1016/j.biomaterials.2015.10.024. Epub 2015 Oct 22.

PMID:
26497428
30.

Effectiveness of a novel biodegradable polymer, sirolimus-eluting stent platform in percutaneous coronary intervention.

Dominici M, Arrivi A, Bazzucchi M, De Paolis M, Milici C, Bock C, Placanica A, Lazzari L, Diletti R, Boschetti E.

Minerva Cardioangiol. 2016 Feb;64(1):1-8. Epub 2015 Oct 7.

PMID:
26446510
31.

VALIDATION OF THE ITALIAN VERSION OF THE COPING INVENTORY FOR STRESSFUL SITUATIONS-SHORT VERSION AMONG HOSPITAL-BASED NURSES.

Pisanti R, Melchiori FM, Lombardo C, Sagliano T, Violani C, Lazzari L, Lazzari D.

Psychol Rep. 2015 Oct;117(2):457-72. doi: 10.2466/08.03.PR0.117c22z1. Epub 2015 Oct 7.

PMID:
26444831
32.

Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn's disease patients in a mouse model of colitis.

Forte D, Ciciarello M, Valerii MC, De Fazio L, Cavazza E, Giordano R, Parazzi V, Lazzari L, Laureti S, Rizzello F, Cavo M, Curti A, Lemoli RM, Spisni E, Catani L.

Stem Cell Res Ther. 2015 Sep 9;6:170. doi: 10.1186/s13287-015-0166-2.

33.

How we make cell therapy in Italy.

Montemurro T, Viganò M, Budelli S, Montelatici E, Lavazza C, Marino L, Parazzi V, Lazzari L, Giordano R.

Drug Des Devel Ther. 2015 Aug 20;9:4825-34. doi: 10.2147/DDDT.S80403. eCollection 2015.

34.

Protein O-mannosylation is crucial for human mesencyhmal stem cells fate.

Ragni E, Lommel M, Moro M, Crosti M, Lavazza C, Parazzi V, Saredi S, Strahl S, Lazzari L.

Cell Mol Life Sci. 2016 Jan;73(2):445-58. doi: 10.1007/s00018-015-2007-y. Epub 2015 Aug 6.

PMID:
26245304
35.

Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications.

Angeli F, Reboldi G, Poltronieri C, Lazzari L, Sordi M, Garofoli M, Bartolini C, Verdecchia P.

Ther Adv Cardiovasc Dis. 2015 Dec;9(6):412-24. doi: 10.1177/1753944715594528. Epub 2015 Jul 19. Review.

PMID:
26194489
36.

Extensive Characterization of Platelet Gel Releasate From Cord Blood in Regenerative Medicine.

Parazzi V, Lavazza C, Boldrin V, Montelatici E, Pallotti F, Marconi M, Lazzari L.

Cell Transplant. 2015;24(12):2573-84. doi: 10.3727/096368915X687471. Epub 2015 Feb 18.

PMID:
25695232
37.

Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer.

Arena S, Bellosillo B, Siravegna G, Martínez A, Cañadas I, Lazzari L, Ferruz N, Russo M, Misale S, González I, Iglesias M, Gavilan E, Corti G, Hobor S, Crisafulli G, Salido M, Sánchez J, Dalmases A, Bellmunt J, De Fabritiis G, Rovira A, Di Nicolantonio F, Albanell J, Bardelli A, Montagut C.

Clin Cancer Res. 2015 May 1;21(9):2157-66. doi: 10.1158/1078-0432.CCR-14-2821. Epub 2015 Jan 26.

38.

How far are we from the clinical use of placental-derived mesenchymal stem cells?

Fierabracci A, Lazzari L, Muraca M, Parolini O.

Expert Opin Biol Ther. 2015 May;15(5):613-7. doi: 10.1517/14712598.2015.1000856. Epub 2015 Jan 5.

PMID:
25556657
39.

Airway fistula closure after stem-cell infusion.

Petrella F, Spaggiari L, Acocella F, Barberis M, Bellomi M, Brizzola S, Donghi S, Giardina G, Giordano R, Guarize J, Lazzari L, Montemurro T, Pastano R, Rizzo S, Toffalorio F, Tosoni A, Zanotti M.

N Engl J Med. 2015 Jan 1;372(1):96-7. doi: 10.1056/NEJMc1411374. No abstract available.

40.

Defining the identity of human adipose-derived mesenchymal stem cells.

Montelatici E, Baluce B, Ragni E, Lavazza C, Parazzi V, Mazzola R, Cantarella G, Brambilla M, Giordano R, Lazzari L.

Biochem Cell Biol. 2015 Feb;93(1):74-82. doi: 10.1139/bcb-2014-0094. Epub 2014 Oct 20.

PMID:
25472894
41.

Urban rivers as conveyors of hydrocarbons to sediments of estuarine areas: source characterization, flow rates and mass accumulation.

Mauad CR, Wagener Ade L, Massone CG, Aniceto Mda S, Lazzari L, Carreira RS, Farias Cde O.

Sci Total Environ. 2015 Feb 15;506-507:656-66. doi: 10.1016/j.scitotenv.2014.11.033. Epub 2014 Nov 27.

PMID:
25434473
42.

Diet composition transiently modulates proliferative and potency features of human cord blood-derived mesenchymal stem cells.

Ragni E, Parazzi V, Crosti M, Moro M, Giordano R, Lazzari L.

Int J Biochem Cell Biol. 2014 Oct;55:269-78. doi: 10.1016/j.biocel.2014.09.017. Epub 2014 Sep 22.

PMID:
25256683
43.

RAF suppression synergizes with MEK inhibition in KRAS mutant cancer cells.

Lamba S, Russo M, Sun C, Lazzari L, Cancelliere C, Grernrum W, Lieftink C, Bernards R, Di Nicolantonio F, Bardelli A.

Cell Rep. 2014 Sep 11;8(5):1475-83. doi: 10.1016/j.celrep.2014.07.033. Epub 2014 Sep 4.

44.

Dissection of the cord blood stromal component reveals predictive parameters for culture outcome.

Barilani M, Lavazza C, Viganò M, Montemurro T, Boldrin V, Parazzi V, Montelatici E, Crosti M, Moro M, Giordano R, Lazzari L.

Stem Cells Dev. 2015 Jan 1;24(1):104-14. doi: 10.1089/scd.2014.0160.

45.

The ROR1 pseudokinase diversifies signaling outputs in MET-addicted cancer cells.

Gentile A, Lazzari L, Benvenuti S, Trusolino L, Comoglio PM.

Int J Cancer. 2014 Nov 15;135(10):2305-16. doi: 10.1002/ijc.28879. Epub 2014 Apr 15.

46.

Blockade of EGFR and MEK intercepts heterogeneous mechanisms of acquired resistance to anti-EGFR therapies in colorectal cancer.

Misale S, Arena S, Lamba S, Siravegna G, Lallo A, Hobor S, Russo M, Buscarino M, Lazzari L, Sartore-Bianchi A, Bencardino K, Amatu A, Lauricella C, Valtorta E, Siena S, Di Nicolantonio F, Bardelli A.

Sci Transl Med. 2014 Feb 19;6(224):224ra26. doi: 10.1126/scitranslmed.3007947.

47.

Autologous mesenchymal stem cell therapy for progressive supranuclear palsy: translation into a phase I controlled, randomized clinical study.

Giordano R, Canesi M, Isalberti M, Isaias IU, Montemurro T, Viganò M, Montelatici E, Boldrin V, Benti R, Cortelezzi A, Fracchiolla N, Lazzari L, Pezzoli G.

J Transl Med. 2014 Jan 17;12:14. doi: 10.1186/1479-5876-12-14.

48.

An 'in-cell trial' to assess the efficacy of a monovalent anti-MET antibody as monotherapy and in association with standard cytotoxics.

Benvenuti S, Gentile A, Lazzari L, Arnesano A, Trusolino L, Comoglio PM.

Mol Oncol. 2014 Mar;8(2):378-88. doi: 10.1016/j.molonc.2013.12.006. Epub 2013 Dec 18.

49.

Progression of renal artery stenosis after renal denervation. Impact on 24-hour blood pressure.

Pucci G, Battista F, Lazzari L, Dominici M, Boschetti E, Schillaci G.

Circ J. 2014;78(3):767-8. Epub 2013 Nov 27. No abstract available.

50.

Assessing cytokines' talking patterns following experimental myocardial damage by applying Shannon's information theory.

Ciulla MM, De Marco F, Montelatici E, Lazzari L, Perrucci GL, Magrini F.

J Theor Biol. 2014 Feb 21;343:25-31. doi: 10.1016/j.jtbi.2013.10.019. Epub 2013 Nov 7.

PMID:
24211523

Supplemental Content

Loading ...
Support Center